المؤلفون: Deshantri AK; Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.; Biological Research Pharmacology Department, Sun Pharma Advanced Research Company Ltd. Vadodara, India., Fens MHAM; Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Ruiter RWJ; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands., Metselaar JM; Enceladus Pharmaceuticals, Naarden, the Netherlands.; Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany., Storm G; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.; Department of Biomaterials Science and Technology, University of Twente, Enschede, The Netherlands., Mandhane SN; Biological Research Pharmacology Department, Sun Pharma Advanced Research Company Ltd. Vadodara, India., Graat GHM; Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Metabolic and Endocrine Diseases, University Medical Center Utrecht, Utrecht, The Netherlands., Lentjes EGW; Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Metabolic and Endocrine Diseases, University Medical Center Utrecht, Utrecht, The Netherlands., Yuan H; Kuros Biosciences BV, Bilthoven, The Netherlands., de Bruijn JD; Kuros Biosciences BV, Bilthoven, The Netherlands.; The School of Engineering and Materials Science, Queen Mary University of London, London, United Kingdom., Mutis T; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands., Martens ACM; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands., Groen RWJ; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands., Schiffelers RM; Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.

المصدر: HemaSphere [Hemasphere] 2020 Aug 27; Vol. 4 (5), pp. e463. Date of Electronic Publication: 2020 Aug 27 (Print Publication: 2020).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE

المؤلفون: Varela-Moreira A; Laboratory of Clinical Chemistry and Hematology (LKCH), University Medical Center Utrecht, Heidelberglaan 100, 3584, CX, Utrecht, the Netherlands.; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Universiteitsweg 99, 3584, CG, Utrecht, the Netherlands., van Straten D; Laboratory of Clinical Chemistry and Hematology (LKCH), University Medical Center Utrecht, Heidelberglaan 100, 3584, CX, Utrecht, the Netherlands., van Leur HF; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Universiteitsweg 99, 3584, CG, Utrecht, the Netherlands., Ruiter RWJ; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, De Boelelaan 1118, 1182, DB, Amsterdam, the Netherlands., Deshantri AK; Laboratory of Clinical Chemistry and Hematology (LKCH), University Medical Center Utrecht, Heidelberglaan 100, 3584, CX, Utrecht, the Netherlands.; Biological Research Pharmacology Department, Sun Pharma Advanced Research Company Ltd., Vadodara, India., Hennink WE; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Universiteitsweg 99, 3584, CG, Utrecht, the Netherlands., Fens MHAM; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Universiteitsweg 99, 3584, CG, Utrecht, the Netherlands., Groen RWJ; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, De Boelelaan 1118, 1182, DB, Amsterdam, the Netherlands., Schiffelers RM; Laboratory of Clinical Chemistry and Hematology (LKCH), University Medical Center Utrecht, Heidelberglaan 100, 3584, CX, Utrecht, the Netherlands.; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Universiteitsweg 99, 3584, CG, Utrecht, the Netherlands.

المصدر: International journal of pharmaceutics: X [Int J Pharm X] 2020 May 16; Vol. 2, pp. 100049. Date of Electronic Publication: 2020 May 16 (Print Publication: 2020).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101753452 Publication Model: eCollection Cited Medium: Internet ISSN: 2590-1567 (Electronic) Linking ISSN: 25901567 NLM ISO Abbreviation: Int J Pharm X Subsets: PubMed not MEDLINE

المؤلفون: Holthof LC; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands., van der Horst HJ; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands., van Hal-van Veen SE; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands., Ruiter RWJ; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands., Li F; Department of Pharmacology & Therapeutics, Roswell Park Comprehensive Cancer Center, New York, NJ USA., Buijze M; Department of Otolaryngology-Head and Neck Surgery, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands., Andersen MN; Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark.; Department of Biomedicine, Aarhus University, Aarhus, Denmark.; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark., Yuan H; Kuros Biosciences BV, Bilthoven, the Netherlands., de Bruijn J; Kuros Biosciences BV, Bilthoven, the Netherlands.; The School of Engineering and Materials Science, Queen Mary University of London, London, UK., van de Donk NWCJ; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands., Lokhorst HM; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands., Zweegman S; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands., Groen RWJ; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands t.mutis@vumc.nl r.groen@vumc.nl., Mutis T; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands t.mutis@vumc.nl r.groen@vumc.nl.

المصدر: Haematologica [Haematologica] 2020 Jan 31; Vol. 105 (2), pp. e80-e83. Date of Electronic Publication: 2020 Jan 31 (Print Publication: 2020).

نوع المنشور: Letter; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

مواضيع طبية MeSH: Indolizines* , Multiple Myeloma*/drug therapy, Survivin/*antagonists & inhibitors, Benzodioxoles ; Humans

المؤلفون: Naik J; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, the Netherlands., Themeli M; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, the Netherlands., de Jong-Korlaar R; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, the Netherlands., Ruiter RWJ; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, the Netherlands., Poddighe PJ; Department of Clinical Genetics, Amsterdam UMC, VU University Medical Center, Amsterdam, the Netherlands., Yuan H; Kuros Biosciences BV, Bilthoven, the Netherlands., de Bruijn JD; Kuros Biosciences BV, Bilthoven, the Netherlands.; The School of Engineering and Materials Science, Queen Mary University of London, UK., Ossenkoppele GJ; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, the Netherlands., Zweegman S; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, the Netherlands., Smit L; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, the Netherlands., Mutis T; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, the Netherlands., Martens ACM; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, the Netherlands., van de Donk NWCJ; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, the Netherlands., Groen RWJ; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, the Netherlands r.groen@vumc.nl.

المصدر: Haematologica [Haematologica] 2019 Mar; Vol. 104 (3), pp. e100-e103. Date of Electronic Publication: 2018 Sep 06.

نوع المنشور: Letter

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

مواضيع طبية MeSH: Molecular Targeted Therapy*, ADP-ribosyl Cyclase 1/*antagonists & inhibitors , Antineoplastic Agents/*therapeutic use , Leukemia, Myeloid, Acute/*drug therapy , Leukemia, Myeloid, Acute/*metabolism , Membrane Glycoproteins/*antagonists & inhibitors , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/*drug therapy , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/*metabolism, Adult ; Antineoplastic Agents/pharmacology ; Female ; Humans ; Leukemia, Myeloid, Acute/diagnosis ; Male ; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/diagnosis ; Treatment Outcome

المؤلفون: Deshantri AK; Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, The Netherlands; Biological Research Pharmacology Department, Sun Pharma Advanced Research Company Ltd., Vadodara, India., Fens MH; Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, The Netherlands; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Ruiter RWJ; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Metselaar JM; Enceladus Pharmaceuticals, Naarden, The Netherlands; Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany., Storm G; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Biomaterials Science and Technology, University of Twente, Enschede, The Netherlands., van Bloois L; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Varela-Moreira A; Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, The Netherlands; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Mandhane SN; Biological Research Pharmacology Department, Sun Pharma Advanced Research Company Ltd., Vadodara, India., Mutis T; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Martens ACM; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Groen RWJ; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Schiffelers RM; Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, The Netherlands; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. Electronic address: R.M.Schiffelers@uu.nl.

المصدر: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2019 Feb 28; Vol. 296, pp. 232-240. Date of Electronic Publication: 2019 Jan 22.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents, Hormonal/*administration & dosage , Dexamethasone/*administration & dosage , Glucocorticoids/*administration & dosage , Multiple Myeloma/*drug therapy, Animals ; Body Weight/drug effects ; Bone and Bones/metabolism ; Cell Line, Tumor ; Disease Models, Animal ; Female ; Humans ; Liposomes ; Mice, Knockout ; Multiple Myeloma/metabolism ; Multiple Myeloma/pathology ; Tissue Distribution ; Tumor Burden/drug effects